» Articles » PMID: 30622213

N-degron and C-degron Pathways of Protein Degradation

Overview
Specialty Science
Date 2019 Jan 10
PMID 30622213
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

This perspective is partly review and partly proposal. N-degrons and C-degrons are degradation signals whose main determinants are, respectively, the N-terminal and C-terminal residues of cellular proteins. N-degrons and C-degrons include, to varying extents, adjoining sequence motifs, and also internal lysine residues that function as polyubiquitylation sites. Discovered in 1986, N-degrons were the first degradation signals in short-lived proteins. A particularly large set of C-degrons was discovered in 2018. We describe multifunctional proteolytic systems that target N-degrons and C-degrons. We also propose to denote these systems as "N-degron pathways" and "C-degron pathways." The former notation replaces the earlier name "N-end rule pathways." The term "N-end rule" was introduced 33 years ago, when only some N-terminal residues were thought to be destabilizing. However, studies over the last three decades have shown that all 20 amino acids of the genetic code can act, in cognate sequence contexts, as destabilizing N-terminal residues. Advantages of the proposed terms include their brevity and semantic uniformity for N-degrons and C-degrons. In addition to being topologically analogous, N-degrons and C-degrons are related functionally. A proteolytic cleavage of a subunit in a multisubunit complex can create, at the same time, an N-degron (in a C-terminal fragment) and a spatially adjacent C-degron (in an N-terminal fragment). Consequently, both fragments of a subunit can be selectively destroyed through attacks by the N-degron and C-degron pathways.

Citing Articles

Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.


Clozapine as an E3 Ligand for PROTAC Technology.

Takano R, Ohoka N, Kurohara T, Arakawa N, Ohgane K, Inoue T ACS Med Chem Lett. 2025; 16(2):258-262.

PMID: 39967646 PMC: 11831399. DOI: 10.1021/acsmedchemlett.4c00500.


Manipulating autophagic degradation in human diseases: from mechanisms to interventions.

Zhang Y, Liu X, Klionsky D, Lu B, Zhong Q Life Med. 2025; 1(2):120-148.

PMID: 39871921 PMC: 11749641. DOI: 10.1093/lifemedi/lnac043.


Exploration of degrons and their ability to mediate targeted protein degradation.

Harris Jr T, Trader D RSC Med Chem. 2025; .

PMID: 39867589 PMC: 11758578. DOI: 10.1039/d4md00787e.


Molecular Symphony of Mitophagy: Ubiquitin-Specific Protease-30 as a Maestro for Precision Management of Neurodegenerative Diseases.

Siwach A, Patel H, Khairnar A, Parekh P CNS Neurosci Ther. 2025; 31(1):e70192.

PMID: 39840724 PMC: 11751875. DOI: 10.1111/cns.70192.


References
1.
Finley D, Chen X, Walters K . Gates, Channels, and Switches: Elements of the Proteasome Machine. Trends Biochem Sci. 2015; 41(1):77-93. PMC: 4706478. DOI: 10.1016/j.tibs.2015.10.009. View

2.
Dougan D, Varshavsky A . Understanding the Pro/N-end rule pathway. Nat Chem Biol. 2018; 14(5):415-416. DOI: 10.1038/s41589-018-0045-0. View

3.
Balchin D, Hayer-Hartl M, Hartl F . In vivo aspects of protein folding and quality control. Science. 2016; 353(6294):aac4354. DOI: 10.1126/science.aac4354. View

4.
Tasaki T, Sriram S, Park K, Kwon Y . The N-end rule pathway. Annu Rev Biochem. 2012; 81:261-89. PMC: 3610525. DOI: 10.1146/annurev-biochem-051710-093308. View

5.
Koren I, Timms R, Kula T, Xu Q, Li M, Elledge S . The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons. Cell. 2018; 173(7):1622-1635.e14. PMC: 6003881. DOI: 10.1016/j.cell.2018.04.028. View